To see all protocols that comply with the WHO Essential Medicine List 

This resource provides guidance on how to safely undertake the procedure. Institutional practice may vary in accordance with local policy.

Only health care professionals who have attained competency (as per institutional guidelines) should perform this procedure.

Clinical safety note
There are physical and operational differences between different brands of elastomeric infusion systems (elastomeric infusors). Always refer to the operator's manual for a complete list of all warnings and precautions associated with these devices. Flow rates of these devices can be affected by variables such as heat, cold, presence of fever and hypertension. See the ISMP safety alert regarding the rapid infusion of high dose fluorouracil.

Only health care professionals who have attained competency as per institutional guidelines on the safe administration, handling and waste management of cytotoxics, central venous access device care and elastomeric infusion system management should perform this procedure. 

This document reflects what is currently regarded as safe practice. While every effort has been made to ensure the accuracy of the content at the time of publication, the Cancer Institute NSW does not accept any liability, with respect to loss, damage, injury or expense arising from any such errors or omission in the contents of this work. Any reference throughout the document to specific pharmaceuticals and/or medical products as examples does not imply endorsement of any of these products. Use is subject to eviQ’s disclaimer available at

Send feedback for this page

First approved:
Last reviewed:
Review due:

The currency of this information is guaranteed only up until the date of printing, for any updates please check:

14 Jul 2020